Steve Schonfeld’s Indivior Pharmaceuticals INDV Stock Holding History

Steve Schonfeld’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.37M	Buy	+130,982	New	+$4.75M	0.02%	621
2026 Q1	–	Sell	-34,835	Closed	-$1.25M	–	2434
2025 Q4	$1.25M	Sell	34,835 -1,297	-4%	-$39.6K	0.01%	1035
2025 Q3	$871K	Buy	+36,132	New	+$756K	0.01%	1442
2025 Q2	–	Sell	-178,825	Closed	-$1.7M	–	2262
2025 Q1	$1.7M	Buy	178,825 +43,164	+32%	+$454K	0.01%	1031
2024 Q4	$1.69M	Buy	+135,661	New	+$1.4M	0.01%	902
2024 Q3	–	Sell	-17,398	Closed	-$280K	–	2213
2024 Q2	$280K	Buy	+17,398	New	+$314K	﹤0.01%	1717

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steve Schonfeld's INDV Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 130,982 shares worth $5.37M. The stake represents 0.02% of the portfolio and ranks #621 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in INDV as recently as Q4 2025.

Steve Schonfeld first reported a position in INDV in Q2 2024 and has held it in 6 quarters since. 335 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Steve Schonfeld held 130,982 shares of Indivior Pharmaceuticals worth $5.37M as of Q2 2026.
Indivior Pharmaceuticals was a new Steve Schonfeld position in Q2 2026.
Indivior Pharmaceuticals made up 0.02% of Steve Schonfeld's portfolio in Q2 2026, its #621 holding.
Steve Schonfeld first reported a position in Indivior Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
335 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.